Bull
$2.25
Szenariopreis
$0.732
+0.022 (+3.06%)Zum Schluss
The Hain Celestial Group, Inc. is a health and wellness company. The Company is focused on delivering nutrition and well-being. Its segments include North America and International. The North America segment includes United States and Canada. The International segment includes United Kingdom and Western Europe. The Company’s products across beverages, yogurt, baby/kids and meal preparation are marketed and sold in over 70 countries around the world. Its brands include Celestial Seasonings teas, The Greek Gods yogurt, Earth's Best Organic and Ella's Kitchen baby and kid's foods, Joya and Natumi plant-based beverages, Hartley’s jelly, as well as Cully & Sully, Yorkshire Provender, and New Covent Garden soups, among others. Its personal care products include JASON, Avalon Organics, Alba Botanica, and Live Clean. Its meal prep brands include Gale's, Farmhouse Fare, Rose's, Linda McCartney's, Frank Cooper's, Spectrum, MaraNatha, Imagine, The Greek Gods, and Cully & Sully.
Hain Celestial Group Inc is currently trading at $0.7319, which is below the recent analyst price targets of 81c and $1. This suggests that while there is potential for upside, the stock is not yet at a favorable buy point considering its recent performance and analyst downgrades. The company's RSI is at 54.264, indicating it is neither overbought nor oversold, which supports a hold strategy. The main risk is the significant revenue decline of 13% year-over-year reported in Q3, which could continue to impact profitability.
Jefferies
—
2026-07-07
Jefferies
2026-07-07
Kursziel
—
Mizuho
$1
2026-05-04
Mizuho
2026-05-04
Kursziel
$1
William Blair
—
2026-04-09
William Blair
2026-04-09
Kursziel
—
Barclays
—
2026-03-16
Barclays
2026-03-16
Kursziel
—
Barclays
$0.50
2026-03-13
Barclays
2026-03-13
Kursziel
$0.50
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Hain Celestial Group to Release Financial Results

Celestial Seasonings Expands Anytime Wellness Tea Line with New Blends

Celestial Seasonings Expands Anytime Wellness Tea Collection

Barfresh Food Group Reports 92% Revenue Growth, Positioned for 2H26 Inflection

Hain Celestial Reports Reduced Loss in Q3
The Hain Celestial Group, Inc. is a health and wellness company. The Company is focused on delivering nutrition and well-being. Its segments include North America and International. The North America segment includes United States and Canada. The International segment includes United Kingdom and Western Europe. The Company’s products across beverages, yogurt, baby/kids and meal preparation are marketed and sold in over 70 countries around the world. Its brands include Celestial Seasonings teas, The Greek Gods yogurt, Earth's Best Organic and Ella's Kitchen baby and kid's foods, Joya and Natumi plant-based beverages, Hartley’s jelly, as well as Cully & Sully, Yorkshire Provender, and New Covent Garden soups, among others. Its personal care products include JASON, Avalon Organics, Alba Botanica, and Live Clean. Its meal prep brands include Gale's, Farmhouse Fare, Rose's, Linda McCartney's, Frank Cooper's, Spectrum, MaraNatha, Imagine, The Greek Gods, and Cully & Sully. It operates in the Consumer Non-Cyclicals sector (FOOD AND KINDRED PRODUCTS industry).
Hain Celestial Group Inc is currently trading at $0.7319, which is below the recent analyst price targets of 81c and $1. This suggests that while there is potential for upside, the stock is not yet at a favorable buy point considering its recent performance and analyst downgrades. The company's RSI is at 54.264, indicating it is neither overbought nor oversold, which supports a hold strategy. The main risk is the significant revenue decline of 13% year-over-year reported in Q3, which could continue to impact profitability.
19 analysts cover HAIN: 6 rate it Buy, 12 Hold and 1 Sell. The average price target is 3.25.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.